课题基金 / 基金详情

Identifying mechanisms of resistance to novel hormonal agents in patients with castrate-resistant prostate cancer

Identifying mechanisms of resistance to novel hormonal agents in patients with castrate-resistant prostate cancer
确定去势抵抗性前列腺癌患者对新型激素药物的耐药机制
批准号:
nhmrc : 1052210
负责人:
A/Pr Arun Azad
金额:
$28.01万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Early Career Fellowships
财政年份:
2013
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2013-01-01 至 2017-12-31

项目摘要

项目成果

A/Pr Arun Azad的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
I am a medical oncologist focused on prostate cancer, a disease which kills over 3000 Australian men every year. Recent studies have shown that new hormone treatments help men with advanced prostate cancer live longer. Unfortunately, while these drugs are effective when first started, prostate cancers eventually become resistant to them and start growing again. By looking at why these drugs stop working, I hope to find better treatments for Australian men with advanced prostate cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel targeting of therapy-resistant prostate cancer cells.
  • 批准号:
    nhmrc : 1140222
  • 项目类别:
    Project Grants
  • 资助金额:
    $40.36万
  • 财政年份:
    2018
  • 负责人:
    A/Pr Arun Azad
  • 依托单位:
A novel strategy for targeting castrate-resistant prostate cancer
  • 批准号:
    nhmrc : 1138242
  • 项目类别:
    Project Grants
  • 资助金额:
    $54.05万
  • 财政年份:
    2018
  • 负责人:
    A/Pr Arun Azad
  • 依托单位:
Novel targeting of therapy-resistant prostate cancer cells.
  • 批准号:
    nhmrc : GNT1140222
  • 项目类别:
    Project Grants
  • 资助金额:
    $59.7万
  • 财政年份:
    2018
  • 负责人:
    A/Pr Arun Azad
  • 依托单位:
A novel strategy for targeting castrate-resistant prostate cancer
  • 批准号:
    nhmrc : GNT1138242
  • 项目类别:
    Project Grants
  • 资助金额:
    $79.94万
  • 财政年份:
    2018
  • 负责人:
    A/Pr Arun Azad
  • 依托单位:
国内基金
海外基金
Exploring the Intrinsic Mechanisms of CEO Turnover and Market
  • 批准号:
    --
  • 项目类别:
    外国学者研究基金
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    HAOFEI Z
  • 依托单位:
Exploring the Intrinsic Mechanisms of CEO Turnover and Market Reaction: An Explanation Based on Information Asymmetry
  • 批准号:
    W2433169
  • 项目类别:
    外国学者研究基金项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    HAOFEI ZHANG
  • 依托单位:
Erk1/2/CREB/BDNF通路在CSF1R相关性白质脑病致病机制中的作用研究
  • 批准号:
    82371255
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    曹立
  • 依托单位:
Foxc2介导Syap1/Akt信号通路调控破骨/成骨细胞分化促进颞下颌关节骨关节炎的机制研究
  • 批准号:
    82370979
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    张善勇
  • 依托单位: